Last updated: September 8, 2023
Sponsor: Gregoire Wuerzner; MD
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
White chocolate
Dark chocolate
Clinical Study ID
NCT05755217
2022-01359
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria for healthy volunteers:
- Age ≥ 18 years old
- ability to understand the study protocol and to sign an informed consent. Inclusion criteria for CKD patients:
- Age ≥18 years old,
- CKD stage 1-3,
- ability to understand the study protocol and to sign an informed consent
Exclusion
Exclusion Criteria:
- Lactose or cocoa intolerance,
- Diabetes,
- any severe digestive issue and liver disease,
- history of kidney stones,
- inability to follow the procedures of the study, e.g. due to language problems,dementia, etc.
- pregnant women
- healthy volunteers taking antihypertensive medication
- healthy volunteers having a known kidney malformation or abnormality
- healthy volunteers with albuminuria and/or hematuria in the urine sample.
- CKD patients with an eGFR<30ml/min/1.73m2
- CKD patients with measured kalemia of > 5.5mmol/l in the last three months.
Study Design
Total Participants: 32
Treatment Group(s): 2
Primary Treatment: White chocolate
Phase:
Study Start date:
February 22, 2023
Estimated Completion Date:
October 01, 2024
Study Description
Connect with a study center
University Hospital of Lausanne (CHUV)
Lausanne, VD 1011
SwitzerlandActive - Recruiting
Department of Nephrology, Centre Hospitalier Universitaire Vaudois
Lausanne, Vaud 1011
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.